Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single 26Al exposure

Toxicological Sciences

Volumn 64, Issue 1, 2001, Pages 77-82

  Yokel, Robert A ^a   Rhineheimer, Susan S ^a   Sharma, Pankaj ^b   Elmore, David ^b   McNamara, Patrick J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Accelerator mass spectrometry; Aluminum; Brain; Chelation therapy; Desferrioxamine; Half life; Rat

Indexed keywords

ALUMINUM; CHELATING AGENT; DEFEROXAMINE MESYLATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN DISEASE; BRAIN LEVEL; CLEARANCE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSIS; EXPOSURE; HALF LIFE TIME; INFUSION; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; RAT;

EID: 0035167306     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/64.1.77     Document Type: Article

References (39)

1. Metabolism and toxicity of aluminum in renal failure
2. The dialysis encephalopathy syndrome. Possible aluminum intoxication
3. 26Al determination by accelerator mass spectrometry
4. Bone disease in moderate renal failure: Cause, nature and prevention
5. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy
6. Intramuscular desferrioxamine in patients with Alzheimer's disease
7. Location of aluminium and gallium in human neuroblastoma cells treated with metal-chelating agent complexes
8. Effects of silicon, citrate and the fasting state on the intestinal absorption of aluminum in rats
9. 26Al in rats
10. Aluminum-26 as a biological tracer using accelerator mass spectrometry
11. RSTRIP: Pharmacokinetic data stripping/least squares parameter optimization
12. Metabolism and possible health effects of aluminum
13. Tissue turnover of aluminum and Ga-67: Effect of iron status
14. Tissue aluminium distribution in growing, mature and ageing rats: Relationship to changes in gut, kidney and bone metabolism
15. A reexamination of aluminum in Alzheimer's disease: Analysis by energy dispersive X-ray microprobe and flameless absorption spectrophotometry
16. 26Al
17. 26Al tracer experiment by accelerator mass spectrometry and its application to the studies for amyotrophic lateral sclerosis and Alzheimer's disease
18. Blood and urine concentrations of aluminium among workers exposed to aluminium flake powders
19. Brain trace element concentrations in aging
20. Citrate binding of Al3+ and Fe3+
21. Brain aluminum in aging and Alzheimer disease
22. Interspecies scaling in pharmacokinetics
23. Tissue aluminum concentrations stability over time, relationship to age, and dietary intake
24. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat
25. Human metabolism of aluminium-26 and gallium-67 injected as citrates
26. Correlation of drug-related aluminum intake and dialysis treatment with deposition of argyrophilic aluminum-containing inclusions in CNS and in organ systems of patients with dialysis-associated encephalopathy
27. PRIME Lab AMS performance, upgrades, and research applications
28. Trace elements in human tissues. 1. A semi-quantitative spectrographic survey
29. Statistical analysis of lung trace element levels
30. 26aluminum in rats measured by accelerator mass spectrometry
31. Uptake of trace amounts of aluminum into the brain from drinking water
32. Aluminum chelation: Chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine
33. The toxicology of aluminum in the brain: A review
34. Prevention and treatment of aluminum toxicity including chelation therapy: Status and research needs
35. Elevated aluminum persists in serum and tissues of rabbits after a six-hour infusion
36. Aluminum toxicokinetics: An updated mini-review
37. Aluminum bioavailability from drinking water is very low and is not appreciably influenced by stomach contents or water hardness
38. Serum aluminum levels in Alzheimer's disease and other senile dementias